Loading…
Sangani Hospitals (SANGANI)₹58.00+3.85%Hospital
In the Mar 2026 quarter (consolidated), Sangani Hospitals reported sales of ₹86.19 Cr, up 682.1% from Mar 2025, and net profit of ₹3.01 Cr, up 198.0% year on year. For the year to Mar 2026, sales were ₹107 Cr and net profit ₹4.01 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 10.03 | 8.02 | 8.02 | 10.03 | 11.02 | 20.05 | 86.19 |
| Expenses | 7.97 | 5.98 | 5.98 | 7.98 | 9.97 | 18.94 | 79.71 |
| Operating Profit | 1.99 | 1.99 | 0.99 | 1.99 | 0.99 | 1.01 | 6.99 |
| OPM % | 17.0% | 22.0% | 17.0% | 17.0% | 7.0% | 7.0% | 8.0% |
| Other Income | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 |
| Profit before tax | 1.01 | 2.01 | 2.01 | 2.01 | 1.01 | 1.01 | 6.01 |
| Tax % | 28.0% | 39.0% | 14.0% | 25.0% | 24.0% | 22.0% | 29.0% |
| Net Profit | 1.01 | 1.01 | 2.01 | 2.01 | 1.01 | 1.01 | 3.01 |
| EPS (Rs) | 0.63 | 0.76 | 1.21 | 1.25 | 0.66 | 0.74 | 1.45 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 4.01 | 16.04 | 16.04 | 21.03 | 107 |
| Expenses | 2.99 | 12.95 | 12.96 | 18.95 | 98.64 |
| Operating Profit | 1.01 | 2.99 | 2.99 | 1.99 | 7.99 |
| OPM % | 35.0% | 20.0% | 20.0% | 12.0% | 8.0% |
| Other Income | 0.00 | 0.00 | 0.99 | 1.99 | 0.99 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 1.01 | 0.00 | 1.01 | 1.01 |
| Profit before tax | 1.01 | 2.01 | 4.01 | 3.01 | 8.01 |
| Tax % | 26.0% | 25.0% | 26.0% | 25.0% | 28.0% |
| Exceptional items | 0.00 | −0.04 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.01 | 2.01 | 3.01 | 3.01 | 4.01 |
| EPS (Rs) | 2.67 | 1.54 | 1.97 | 1.89 | 2.18 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 4.01 | 10.03 | 14.04 | 14.03 | 14.04 |
| Reserves | 0.99 | 7.98 | 19.97 | 21.96 | 26.95 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 |
| Other Liabilities | 2.00 | 1.99 | 1.99 | 3.01 | 71.08 |
| Total Liabilities | 7.00 | 20.00 | 35.00 | 39.00 | 114 |
| Fixed Assets | 0.99 | 11.99 | 12.99 | 12.99 | 31.97 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 4.01 |
| Other Assets | 6.01 | 8.01 | 23.01 | 26.01 | 77.08 |
| Inventories | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 |
| Trade receivables | 2.01 | 2.01 | 2.01 | 3.01 | 62.14 |
| Cash & equivalents | 2.99 | 3.99 | 18.95 | 17.96 | 11.96 |
| Total Assets | 7.00 | 20.00 | 35.00 | 39.00 | 114 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 0.00 | 2.99 | 2.99 | 1.99 | 4.99 |
| Cash from investing activity | 0.00 | −11.96 | −0.99 | −0.99 | −9.97 |
| Cash from financing activity | 1.01 | 11.01 | 12.01 | −2.01 | −2.01 |
| Net cash flow | 0.99 | 0.99 | 14.94 | −0.99 | −5.98 |
| Capex | 0.03 | 12.03 | 1.10 | 1.10 | 4.82 |
| Free cash flow | 0.00 | −9.03 | 2.01 | 1.01 | 0.00 |
| CFO / OP % | 16.0% | 99.0% | 130.0% | 124.0% | 84.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 203 | 55 | 52 | 51 | 210 |
| Inventory days | 160 | 34 | 51 | 57 | 7 |
| Days payable | 454 | 45 | 68 | 50 | 264 |
| Cash conversion cycle | −92 | 42 | 33 | 55 | −49 |
| Working capital days | 119 | 41 | 38 | 46 | 29 |
| ROCE % | — | 18.0% | 13.9% | 10.0% | 17.0% |
For the Mar 2026 quarter, Sangani Hospitals reported sales of ₹86.19 Cr, up 682.1% year on year and net profit of ₹3.01 Cr, up 198.0% year on year. The operating margin was 8.0%.
Sangani Hospitals' sales for the year to Mar 2026 were ₹107 Cr.
Net profit for the year to Mar 2026 was ₹4.01 Cr. Earnings per share over the same trailing period were ₹2.18.
Sangani Hospitals reported borrowings of ₹1.99 Cr at Mar 2026, against cash and equivalents of ₹11.96 Cr.
Cash from operations was ₹4.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0 Cr.